ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe
Joshua Heyza(Michigan State University), Steve M. Patrick(Wayne State University), John J. Turchi(University of Indianapolis), Vilvanathan Vinothkumar(Wayne State University), Eric Van Buren(Harvard University), Hirva Mamdani(Wayne State University), Natalie G. Snider-Hoy(Wayne State University), Jacob Lindquist(Wayne State University), Rachelle Rowbotham(Wayne State University), Elmira Ekinci(Wayne State University), Donovan Watza(Wayne State University), Lisa Polin(Wayne State University), Jessica B. Back(Wayne State University), Wei Chen(Gansu University of Traditional Chinese Medicine), Wen Lei(Wayne State University), Ann G. Schwartz(The Barbara Ann Karmanos Cancer Institute), Christopher K. Yunker(Wayne State University), Gerold Bepler(Moffitt Cancer Center)
Cited by 11
Related Papers
Immunotherapy in Lung Cancer: Current Landscape and Future Directions
|Frontiers in Immunology|2022|373
<i>RRM1</i> Modulated In Vitro and In Vivo Efficacy of Gemcitabine and Platinum in Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2006|335
A nonsynonymous functional variant in integrin-αM (encoded by ITGAM) is associated with systemic lupus erythematosus
|Nature Genetics|2008|317
Trends in short-term survival from distant-stage cutaneous melanoma in the United States, 2001-2013 (CONCORD-3)
|JNCI Cancer Spectrum|2020|163
Familial Aggregation of Common Sequence Variants on 15q24-25.1 in Lung Cancer
|JNCI Journal of the National Cancer Institute|2008|152